Ramsay Health Care (RMSYF)
Laaman has an average return of
According to TipRanks.com, Laaman is ranked #5982 out of 7906 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Ramsay Health Care with a $55.75 average price target.
Paradigm Biopharmaceuticals Ltd. (PBIGF)
The company’s shares closed last Tuesday at $0.67, close to its 52-week low of $0.67.
According to TipRanks.com, Hester is a 1-star analyst with an average return of
Currently, the analyst consensus on Paradigm Biopharmaceuticals Ltd. is a Moderate Buy with an average price target of $1.29.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on RMSYF:
- Jarden Reaffirms Their Buy Rating on Star Entertainment Group Limited (EHGRF)
- Austal Limited (AUTLF) Gets a Buy Rating from Citigroup
- Citigroup Believes Bank of Queensland Limited (BKQNF) Won’t Stop Here
- Origin Energy Limited (OGFGF) Receives a Sell from Jarden
- Morgan Stanley Remains a Hold on BHP Group Ltd (BHPLF)